Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles
about
Nanocarriers for vascular delivery of antioxidantsCross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".Flash nanoprecipitation: particle structure and stability.Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation.Effects of block copolymer properties on nanocarrier protection from in vivo clearance.Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.Optimized zein nanospheres for improved oral bioavailability of atorvastatinNitric oxide release: part II. Therapeutic applications.Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano CarriersSingle-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging.Polymer directed self-assembly of pH-responsive antioxidant nanoparticlesKinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacyFormation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitationGelation chemistries for the encapsulation of nanoparticles in composite gel microparticles for lung imaging and drug deliveryNanoparticles as delivery carriers for anticancer prodrugs.Nanocarriers for vascular delivery of anti-inflammatory agentsIonic Flash NanoPrecipitation (iFNP) for the facile, one-step synthesis of inorganic-organic hybrid nanoparticles in water.Human cytosolic glutathione-S-transferases: quantitative analysis of expression, comparative analysis of structures and inhibition strategies of isozymes involved in drug resistance.Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor.Formulation of long-wavelength indocyanine green nanocarriers.Composite fluorescent nanoparticles for biomedical imaging.Nitric oxide release triggered by two-photon excited photoluminescence of engineered nanomaterials.Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticlesAerosol Delivery of Nanoparticles in Uniform Mannitol Carriers Formulated by Ultrasonic Spray Freeze Drying
P2860
Q27027067-C185FC54-6AFE-4739-A17F-88C70C5C0CB2Q30422929-8883DFBB-2CB6-4CCE-A170-3CA157D6A18BQ30668553-E3AB5A75-7607-43F0-AEBC-513AC4C03AB6Q33951477-8473A9EC-9F33-4F57-B98B-F77BA2F4AEF8Q34089117-D1352604-601A-4D4F-BF7D-9DC633113CF9Q34283992-F69FD814-F75F-4E37-84E9-EB62844E1AE7Q35179525-EBDDAB99-8FC4-4D21-BD45-7B968EDEDAAEQ35579500-444CBE89-CD4A-4ED9-ABC0-3A2F5AF94F9FQ35658977-8DED8D9C-0B4D-47E9-B4E1-8EC16A965AC8Q35780982-CB7515F3-D2CC-4ABF-ABA1-67C1FE41D1DDQ35926097-07E0D441-8154-44F5-891E-C8D51521633BQ36176439-3A33320D-9674-45BA-ACCF-11A5A5AC8EF1Q36198686-0831AE94-A1BE-4B6D-953E-F7BBED2520AFQ36372387-72B5D419-6830-4500-B7C9-97449CE01B87Q36390180-645BF93D-9AD2-4C6B-94C0-C82E3E8A9035Q36916351-51E788F3-ADCD-4573-8659-766DA6F09D3FQ37694016-D0F9C04F-5046-476F-85D5-238F20BD94C1Q38002956-314910CA-E269-4403-830A-C93F2FFAF56EQ38176037-C8BFD762-DB8E-4B1D-97E1-5A699C5CCFFDQ38433917-DDC627CE-4F91-4327-984B-B913FFB1FF73Q38724701-71923599-773E-437F-8C15-B77252D7FFE1Q41170076-BE25D7F5-AE4F-4DD5-A8E7-F82CA192BDC7Q47660849-82A73B68-7B47-4B06-B0B3-874583D96AB0Q50484676-A24259A7-926F-4A96-A9D8-4006BFA926A6Q51741120-35889EC4-8101-48E8-ADB4-49EA2C80EB7BQ58555811-FBE79CEF-0874-4738-B97C-E6BB85E698D7Q59291762-A33ACBDC-89E0-4976-AE5A-97E8DF5679D4
P2860
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@ast
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@en
type
label
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@ast
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@en
prefLabel
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@ast
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@en
P2093
P2860
P356
P1476
Stabilization of the nitric ox ...... to PEG-protected nanoparticles
@en
P2093
Anna E Maciag
Douglas H Adamson
Harinath Chakrapani
Joseph E Saavedra
Larry K Keefer
Robert K Prud'homme
Sam Y Hong
Varun Kumar
P2860
P304
P356
10.1021/MP900245H
P407
P577
2010-02-01T00:00:00Z